Correlation Between GlaxoSmithKline PLC and Remarul 16

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Remarul 16 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Remarul 16 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Remarul 16 Februarie, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Remarul 16 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Remarul 16. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Remarul 16.

Diversification Opportunities for GlaxoSmithKline PLC and Remarul 16

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between GlaxoSmithKline and Remarul is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Remarul 16 Februarie in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Remarul 16 Februarie and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Remarul 16. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Remarul 16 Februarie has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Remarul 16 go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Remarul 16

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Remarul 16. In addition to that, GlaxoSmithKline PLC is 2.46 times more volatile than Remarul 16 Februarie. It trades about -0.12 of its total potential returns per unit of risk. Remarul 16 Februarie is currently generating about -0.05 per unit of volatility. If you would invest  2,840  in Remarul 16 Februarie on August 29, 2024 and sell it today you would lose (120.00) from holding Remarul 16 Februarie or give up 4.23% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.21%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Remarul 16 Februarie

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Remarul 16 Februarie 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Remarul 16 Februarie are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Remarul 16 is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

GlaxoSmithKline PLC and Remarul 16 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Remarul 16

The main advantage of trading using opposite GlaxoSmithKline PLC and Remarul 16 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Remarul 16 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Remarul 16 will offset losses from the drop in Remarul 16's long position.
The idea behind GlaxoSmithKline PLC ADR and Remarul 16 Februarie pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules